Drug Profile


Alternative Names: CADA

Latest Information Update: 22 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source; Rega Institute for Medical Research; University of Nevada Reno
  • Class Antivirals
  • Mechanism of Action CD4 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Herpesvirus infections; HIV infections

Most Recent Events

  • 08 Dec 2004 Preclinical trials in HIV infections treatment in Belgium (unspecified route)
  • 08 Dec 2004 Preclinical trials in HIV infections treatment in USA (unspecified route)
  • 08 Dec 2004 A preclinical study has been added to the Viral Infections antimicrobial activity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top